Semler Scientific Releases Q1 Financial Report: Bitcoin Holdings Reach 3,808, Year-to-Date Return at 22.2%
ChainCatcher reports that Nasdaq-listed company Semler Scientific released its financial results for the first quarter ending March 31, 2025, disclosing:
1. As of May 12, 2025, Bitcoin holdings reached 3,808 units, with a fair value of $387.9 million and a total purchase amount of $340 million;
2. As of May 12, 2025, the Q1 Bitcoin yield reached 21.9%, with a year-to-date yield of 22.2%;
3. As of May 12, 2025, the Q1 Bitcoin income amounted to $41.6 million, with year-to-date Bitcoin income reaching $52 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Just about three months after listing, two SK Hynix leveraged ETFs are set to be delisted in the United States.
Tradr ETFs announced that its two leveraged products linked to SK Hynix ADRs will be liquidated and delisted around November 12, with one being long and the other short. Despite only being listed for a few months, their combined scale has shrunk to about $1.3 million, down more than 60% from their peak. SK Hynix's Seoul stock price has fallen 56% from its high, similar products in the industry are generally under pressure, and South Korea has also further tightened regulations on leveraged products.
WTI Price Forecast: Slides further below $100.50; bullish potential seems intact
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.
Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.
Crypto prices
More
